Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The impact of lipidome on breast cancer: a Mendelian randomization study.

  • Authors : Cao Y; Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 33 Badachu Road, Shijingshan, Beijing, 100144, China.; Ai M

Subjects: Lipidomics* ; Neoplasms*; Bayes Theorem

  • Source: Lipids in health and disease [Lipids Health Dis] 2024 Apr 15; Vol. 23 (1), pp. 109. Date of Electronic Publication: 2024 Apr 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-511X

Record details

×
Academic Journal

Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile.

  • Authors : Wang T; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China.; GeneScience Pharmaceuticals Co., Ltd, Changchun, 130012, Jilin, People's Republic of China.

Subjects: CD47 Antigen* ; Neoplasms*/Neoplasms*/Neoplasms*/pathology; Animals

  • Source: Journal of translational medicine [J Transl Med] 2024 Mar 01; Vol. 22 (1), pp. 220. Date of Electronic Publication: 2024 Mar 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

×
Academic Journal

UHPLC-MS/MS Assay for Quantification of Legubicin, a Novel Doxorubicin-Based Legumain-Activated Prodrug, and Its Application to Pharmacokinetic and Tissue Distribution Studies.

  • Authors : Ma L; Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 201203, China.; Shanghai Innostar Bio-Tech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, China.

Subjects: Prodrugs*/Prodrugs*/Prodrugs*/chemistry ; Neoplasms* ; Cysteine Endopeptidases*

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Feb 08; Vol. 29 (4). Date of Electronic Publication: 2024 Feb 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution.

  • Authors : Yang W; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.; Liu S

Subjects: T-Lymphocytes* ; Neoplasms*/Neoplasms*/Neoplasms*/therapy; Humans

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 02; Vol. 43 (1), pp. 38. Date of Electronic Publication: 2024 Feb 02.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

×
Academic Journal

The Graphene Quantum Dots Gated Nanoplatform for Photothermal-Enhanced Synergetic Tumor Therapy.

  • Authors : Wang L; School of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China.; Wang W

Subjects: Quantum Dots*/Quantum Dots*/Quantum Dots*/chemistry ; Graphite*/Graphite*/Graphite*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Jan 27; Vol. 29 (3). Date of Electronic Publication: 2024 Jan 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

The role of ADAR1 through and beyond its editing activity in cancer.

  • Authors : Jiao Y; School of Basic Medicine Sciences, Weifang Medical University, Weifang, 261053, China.; Xu Y

Subjects: RNA-Binding Proteins*/RNA-Binding Proteins*/RNA-Binding Proteins*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/metabolism; Animals

  • Source: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 17; Vol. 22 (1), pp. 42. Date of Electronic Publication: 2024 Jan 17.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

Record details

×
Academic Journal

Perspectives of telemedicine-based services among family caregivers of patients with end-of-life cancer: a qualitative study in mainland China.

  • Authors : Guo J; Department of Palliative Care, Hunan Cancer Hospital, No.283, Tongzipo Road, Yuelu District, Changsha, 410006, Hunan, China.; School of Nursing, University of South China, No.28, Changsheng West Road, Hengyang, 421001, Hunan, China.

Subjects: Telemedicine* ; Neoplasms*/Neoplasms*/Neoplasms*/therapy; Humans

  • Source: BMC palliative care [BMC Palliat Care] 2024 Jan 12; Vol. 23 (1), pp. 16. Date of Electronic Publication: 2024 Jan 12.Publisher: BioMed Central Country of Publication: England NLM ID: 101088685 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-684X

Record details

×
Academic Journal

Uncovering the Anti-Angiogenic Mechanisms of Centella asiatica via Network Pharmacology and Experimental Validation.

  • Authors : Zhao B; Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, China.; Li Y

Subjects: Centella* ; Triterpenes*/Triterpenes*/Triterpenes*/pharmacology ; Neoplasms*

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Jan 11; Vol. 29 (2). Date of Electronic Publication: 2024 Jan 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

Optimized DOX Drug Deliveries via Chitosan-Mediated Nanoparticles and Stimuli Responses in Cancer Chemotherapy: A Review.

  • Authors : Imran H; Department of Biochemistry, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.; Tang Y

Subjects: Chitosan* ; Nanoparticles* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: Molecules (Basel, Switzerland) [Molecules] 2023 Dec 20; Vol. 29 (1). Date of Electronic Publication: 2023 Dec 20.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.

  • Authors : Zhang H; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.; Yue X

Subjects: Cancer-Associated Fibroblasts*/Cancer-Associated Fibroblasts*/Cancer-Associated Fibroblasts*/pathology ; Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Neoplasms*/Neoplasms*/Neoplasms*/pathology

  • Source: Molecular cancer [Mol Cancer] 2023 Oct 02; Vol. 22 (1), pp. 159. Date of Electronic Publication: 2023 Oct 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

Record details

×
  • 1-10 of  94 results for ""Liu C""